Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer (Review)
- Authors:
- He Li
- Yi‑Xin Chen
- Jia‑Gen Wen
- Hong‑Hao Zhou
-
Affiliations: Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China - Published online on: July 26, 2017 https://doi.org/10.3892/ol.2017.6670
- Pages: 3899-3908
-
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Stein U and Schlag PM: Clinical, biological, and molecular aspects of metastasis in colorectal cancer. Recent Results Cancer Res. 176:61–80. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Deliu IC, Georgescu EF and Bezna MC: Analysis of prognostic factors in colorectal carcinoma. Rev Med Chir Soc Med Nat Iasi. 118:808–816. 2014.PubMed/NCBI | |
|
Sethi N and Kang Y: Unravelling the complexity of metastasis-molecular understanding and targeted therapies. Nat Rev Cancer. 11:735–748. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wanebo HJ, LeGolvan M, Paty PB, Saha S, Zuber M, D'Angelica MI and Kemeny NE: Meeting the biologic challenge of colorectal metastases. Clin Exp Metastasis. 29:821–839. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, Birchmeier W and Schlag PM: MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med. 15:59–67. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Stein U, Dahlmann M and Walther W: MACC1-more than metastasis? Facts and predictions about a novel gene. J Mol Med (Berl). 88:11–18. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kokoszyńska K, Kryński J, Rychlewski L and Wyrwicz LS: Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol. 56:317–323. 2009.PubMed/NCBI | |
|
Wang R, Wei Z, Jin H, Wu H, Yu C, Wen W, Chan LN, Wen Z and Zhang M: Autoinhibition of UNC5b revealed by the cytoplasmic domain structure of the receptor. Mol Cell. 33:692–703. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ipsaro JJ, Huang L and Mondragon A: Structures of the spectrin-ankyrin interaction binding domains. Blood. 113:5385–5393. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Reed JC, Doctor KS and Godzik A: The domains of apoptosis: A genomics perspective. Sci STKE. 2004:re92004.PubMed/NCBI | |
|
Shirahata A, Sakata M, Kitamura Y, Sakuraba K, Yokomizo K, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, et al: MACC 1 as a marker for peritoneal-disseminated gastric carcinoma. Anticancer Res. 30:3441–3444. 2010.PubMed/NCBI | |
|
Ge SH, Wu XJ, Wang XH, Xing XF, Zhang LH, Zhu YB, Du H, Dong B, Hu Y and Ji JF: Over-expression of metastasis-associated in colon cancer-1 (MACC1) associates with better prognosis of gastric cancer patients. Chin J Cancer Res. 23:153–159. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Wu Y, Lin L, Liu P, Huang H, Liao W, Zheng D, Zuo Q, Sun L, Huang N, et al: Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. Int J Cancer. 133:1419–1430. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ma J, Ma J, Meng Q, Zhao ZS and Xu WJ: Prognostic value and clinical pathology of MACC-1 and c-MET expression in gastric carcinoma. Pathol Oncol Res. 19:821–832. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Guo T, Yang J, Yao J, Zhang Y, Da M and Duan Y: Expression of MACC1 and c-Met in human gastric cancer and its clinical significance. Cancer Cell Int. 13:1212013. View Article : Google Scholar : PubMed/NCBI | |
|
Sun L, Duan J, Jiang Y, Wang L, Huang N, Lin L, Liao Y and Liao W: Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer. Cancer Lett. 357:242–253. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Burock S, Herrmann P, Wendler I, Niederstrasser M, Wernecke KD and Stein U: Circulating metastasis associated in colon cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker. World J Gastroenterol. 21:333–341. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Shimokawa H, Uramoto H, Onitsuka T, et al: Macc1 amplification predicts postoperative recurrence in lung adenocarcinoma. Ann Oncol. 21:24–25. 2010. | |
|
Shimokawa H, Uramoto H, Onitsuka T, Chundong G, Hanagiri T, Oyama T and Yasumoto K: Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence. J Thorac Cardiovasc Surg. 141:895–898. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Gu CD, Uramoto H, Onitsuka T, Shimokawa H, Iwanami T, Nakagawa M, Oyama T and Tanaka F: Molecular Diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res. 31:1141–1145. 2011.PubMed/NCBI | |
|
Hu X, Fu X, Wen S, Zou X and Liu Y: Prognostic value of MACC1 and c-met expressions in non-small cell lung cancer. Zhongguo Fei Ai Za Zhi. 15:399–403. 2012.(In Chinese). PubMed/NCBI | |
|
Wang Z, Li Z, Wu C, Wang Y, Xia Y, Chen L, Zhu Q and Chen Y: MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer. Med Oncol. 31:7902014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z, Cai M, Weng Y, Zhang F, Meng D, Song J, Zhou H and Xie Z: Circulating MACC1 as a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer. J Cancer Res Clin Oncol. 141:1353–1361. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Huang Y, Zhang H, Cai J, Fang L, Wu J, Ye C, Zhu X and Li M: Overexpression of MACC1 and its significance in human breast cancer progression. Cell Biosci. 3:162013. View Article : Google Scholar : PubMed/NCBI | |
|
Muendlein A, Hubalek M, Geller-Rhomberg S, Gasser K, Winder T, Drexel H, Decker T, Mueller-Holzner E, Chamson M, Marth C and Lang AH: Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients. Eur J Cancer. 50:2134–2141. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kim GE, Lee JS, Park MH and Yoon JH: Metastasis associated in colon cancer 1 predicts poor outcomes in patients with breast cancer. Anal Quant Cytopathol Histpathol. 37:96–104. 2015.PubMed/NCBI | |
|
Qiu J, Huang P, Liu Q, Hong J, Li B, Lu C, Wang L, Wang J and Yuan Y: Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med. 9:1662011. View Article : Google Scholar : PubMed/NCBI | |
|
Qu JH, Chang XJ, Lu YY, Bai WL, Chen Y, Zhou L, Zeng Z, Wang CP, An LJ, Hao LY, et al: Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol. 18:2995–3003. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Chang XJ, Wang CP, Qu JH, Lu YY, Chen Y, Bai WL, Gao XD, Hao LY, Xu GL, Wang H and Yang YP: Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi. 34:748–752. 2012.PubMed/NCBI | |
|
Yang YP, Qu JH, Chang XJ, Lu YY, Bai WL, Dong Z, Wang H, An LJ, Xu ZX, Wang CP, et al: High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma. J Transl Med. 11:412013. View Article : Google Scholar : PubMed/NCBI | |
|
Xie C, Wu J, Yun J, Lai J, Yuan Y, Gao Z, Li M, Li J and Song L: MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. PLoS One. 8:e642352013. View Article : Google Scholar : PubMed/NCBI | |
|
Xie C, Li J, Xie DY, Wu JH, Li MF and Gao ZL: 761 Macc1 protein: A promising immunomarker for the detection of early stage and afp normal hepatocellular carcinomas. J Hepatol. 56:S2992012. View Article : Google Scholar | |
|
Gao S, Lin BY, Yang Z, Zheng ZY, Liu ZK, Wu LM, Xie HY, Zhou L and Zheng SS: Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation. Int J Med Sci. 11:268–275. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ji D, Lu ZT, Li YQ, Liang ZY, Zhang PF, Li C, Zhang JL, Zheng X and Yao YM: MACC1 Expression correlates with PFKFB2 and survival in hepatocellular carcinoma. Asian Pac J Cancer P. 15:999–1003. 2014. View Article : Google Scholar | |
|
Li Y, Lu Z, Liang Z, Ji D, Zhang P, Liu Q, Zheng X and Yao Y: Metastasis-associated in colon cancer-1 is associated with poor prognosis in hepatocellular carcinoma, partly by promoting proliferation through enhanced glucose metabolism. Mol Med Rep. 12:426–434. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Sun DW, Zhang YY, Qi Y, Liu GQ, Chen YG, Ma J and Lv GY: Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: A meta-analysis. Int J Clin Exp Med. 8:4769–4777. 2015.PubMed/NCBI | |
|
Yao Y, Dou C, Lu Z, Zheng X and Liu Q: MACC1 suppresses cell apoptosis in hepatocellular carcinoma by targeting the HGF/c-MET/AKT pathway. Cell Physiol Biochem. 35:983–996. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang RT, Shi HR, Huang HL, Chen ZM, Liu HN and Yuan ZF: Expressions of MACC1, HGF and C-met protein in epithelial ovarian cancer and their significance. Nan Fang Yi Ke Da Xue Xue Bao. 31:1551–1555. 2011.(In Chinese). PubMed/NCBI | |
|
Zhang RT, Ren F and Shi HR: Expression of metastasis-associated in colon cancer-1 in different stages of epithelial ovarian cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 36:47–51. 2014.(In Chinese). PubMed/NCBI | |
|
Li H, Zhang H, Zhao S, Shi Y, Yao J, Zhang Y, Guo H and Liu X: Overexpression of MACC1 and the association with hepatocyte growth factor/c-Met in epithelial ovarian cancer. Oncol Lett. 9:1989–1996. 2015.PubMed/NCBI | |
|
Hu H, Tian D, Chen T, Han R, Sun Y and Wu C: Metastasis-associated in colon cancer 1 is a novel survival-related biomarker for human patients with renal pelvis carcinoma. PLoS One. 9:e1001612014. View Article : Google Scholar : PubMed/NCBI | |
|
Jin Z, Xu N, Guo K, Xu P, Li P, Zhang Y, Li X, Zheng S, Liu C, Xu A and Huang P: Increased expression of metastasis-associated in colon cancer-1 in renal cell carcinoma is associated with poor prognosis. Int J Clin Exp Pathol. 8:3857–3863. 2015.PubMed/NCBI | |
|
Yang T, Kong B, Kuang YQ, Cheng L, Gu JW, Zhang JH, Shu HF, Yu SX, He WQ, Xing XM and Huang HD: Overexpression of MACC1 protein and its clinical implications in patients with glioma. Tumor Biol. 35:815–819. 2014. View Article : Google Scholar | |
|
Hagemann C, Fuchs S, Monoranu CM, Herrmann P, Smith J, Hohmann T, Grabiec U, Kessler AF, Dehghani F, Löhr M, et al: Impact of MACC1 on human malignant glioma progression and patients unfavorable prognosis. Neuro Oncol. 15:1696–1709. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Hong Q, Wang J, Fang Y and Hu C: Downregulated expression of metastasis associated in colon cancer 1 (MACC1) reduces gallbladder cancer cell proliferation and invasion. Tumor Biol. 35:3771–3778. 2014. View Article : Google Scholar | |
|
Chen L, Wang J, Fu L, Zhang B, Zhang H and Ye B: Prognostic significance of metastasis associated in colon cancer 1 (MACC1) expression in patients with gallbladder cancer. J Cancer Res Ther. 10:1052–1056. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li HF, Liu YQ, Shen ZJ, Gan XF, Han JJ, Liu YY, Li HG1 and Huang ZQ: Downregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinoma. Oncol Rep. 33:651–660. 2015.PubMed/NCBI | |
|
Zhang K, Zhang Y, Zhu H, Xue N, Liu J, Shan C and Zhu Q: High expression of MACC1 predicts poor prognosis in patients with osteosarcoma. Tumor Biol. 35:1343–1350. 2014. View Article : Google Scholar | |
|
Zhang K, Tian F, Zhang Y, Zhu Q, Xue N, Zhu H, Wang H and Guo X: MACC1 is involved in the regulation of proliferation, colony formation, invasion ability, cell cycle distribution, apoptosis and tumorigenicity by altering Akt signaling pathway in human osteosarcoma. Tumor Biol. 35:2537–2548. 2014. View Article : Google Scholar | |
|
Zhu M, Xu Y, Mao X, Gao Y, Shao L and Yan F: Overexpression of metastasis-associated in colon cancer-1 associated with poor prognosis in patients with esophageal cancer. Pathol Oncol Res. 19:749–753. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang JJ, Hong Q, Hu CG, Fang YJ and Wang Y: Significance of MACC1 protein expression in esophageal carcinoma. Zhonghua yi xue za zhi. 93:2584–2586. 2013.(In Chinese). PubMed/NCBI | |
|
Meng FJ, Li H, Shi H, Yang Q, Zhang F, Yang Y, Kang L, Zhen T, Dong DY and Han A: MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/β-catenin signaling pathway. PLoS One. 8:e608212013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang G, Kang MX, Lu WJ, Chen Y, Zhang B and Wu YL: MACC1: A potential molecule associated with pancreatic cancer metastasis and chemoresistance. Oncol Lett. 4:783–791. 2012.PubMed/NCBI | |
|
Lederer A, Herrmann P, Seehofer D, Dietel M, Pratschke J, Schlag P and Stein U: Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in klatskin tumor patients. Hepatology. 62:841–850. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Liao X, Liu Y, Shen Z, Gan X, Li H and Huang Z: The expression of MACC1 and its role in the proliferation and apoptosis of salivary adenoid cystic carcinoma. J Oral Pathol Med. 44:810–817. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Guo L, Lu W, Zhang X, Luo D and Zhang H: Metastasis-associated colon cancer-1 is a novel prognostic marker for cervical cancer. Int J Clin Exp Pathol. 7:4150–4155. 2014.PubMed/NCBI | |
|
Shirahata A, Shinmura K, Kitamura Y, Sakuraba K, Yokomizo K, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, et al: MACC1 as a marker for advanced colorectal carcinoma. Anticancer Res. 30:2689–2692. 2010.PubMed/NCBI | |
|
Lang AH, Geller-Rhomberg S, Winder T, Stark N, Gasser K, Hartmann B, Kohler B, Grizelj I, Drexel H and Muendlein A: A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients. BMC Cancer. 12:202012. View Article : Google Scholar : PubMed/NCBI | |
|
Schmid F, Burock S, Klockmeier K, Schlag PM and Stein U: SNPs in the coding region of the metastasis-inducing gene MACC1 and clinical outcome in colorectal cancer. Mol Cancer. 11:492012. View Article : Google Scholar : PubMed/NCBI | |
|
Stein U, Burock S, Herrmann P, Wendler I, Niederstrasser M, Wernecke KD and Schlag PM: Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis. PLos One. 7:e492492012. View Article : Google Scholar : PubMed/NCBI | |
|
Isella C, Mellano A, Galimi F, Petti C, Capussotti L, De Simone M, Bertotti A, Medico E and Muratore A: MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases. Ann Surg. 257:1089–1095. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ren B, Zakharov V, Yang Q, McMahon L, Yu J and Cao W: MACC1 is related to colorectal cancer initiation and early-stage invasive growth. Am J Clin Pathol. 140:701–707. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Harpaz N, Taboada S, Ko HM, Yu J, Yang Q, Xu H and Cao W: Expression of MACC1 and MET in inflammatory bowel disease-associated colonic neoplasia. Inflamm Bowel Dis. 20:703–711. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yamamoto H, Miyoshi N, Mimori K, Hitora T, Tokuoka M, Fujino S, Ellis HL, Ishii H, Noura S, Ohue M, et al: MACC1 expression levels as a novel prognostic marker for colorectal cancer. Oncol Lett. 8:2305–2309. 2014.PubMed/NCBI | |
|
Ilm K, Kemmner W, Osterland M, Burock S, Koch G, Herrmann P, Schlag PM and Stein U: High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients. Mol Cancer. 14:382015. View Article : Google Scholar : PubMed/NCBI | |
|
Koelzer VH, Herrmann P, Zlobec I, Karamitopoulou E, Lugli A and Stein U: Heterogeneity analysis of metastasis associated in colon cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: A retrospective cohort study. BMC Cancer. 15:1602015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhen T, Dai S, Li H, Yang Y, Kang L, Shi H, Zhang F, Yang D, Cai S, He Y, et al: MACC1 promotes carcinogenesis of colorectal cancer via β-catenin signaling pathway. Oncotarget. 5:3756–3769. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kawamura M, Saigusa S, Toiyama Y, Tanaka K, Okugawa Y, Hiro J, Uchida K, Mohri Y, Inoue Y and Kusunoki M: Correlation of MACC1 and MET expression in rectal cancer after neoadjuvant chemoradiotherapy. Anticancer Res. 32:1527–1531. 2012.PubMed/NCBI | |
|
Ge Y, Meng X, Zhou Y, Zhang J and Ding Y: Positive MACC1 expression correlates with invasive behaviors and postoperative liver metastasis in colon cancer. Int J Clin Exp Med. 8:1094–1100. 2015.PubMed/NCBI | |
|
Galimi F, Torti D, Sassi F, Isella C, Corà D, Gastaldi S, Ribero D, Muratore A, Massucco P, Siatis D, et al: Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: Response to met inhibition in patient xenografts and pathologic correlations. Clin Cancer Res. 17:3146–3156. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Boardman LA: Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer. Genome Med. 1:362009. View Article : Google Scholar : PubMed/NCBI | |
|
Nitsche U, Rosenberg R, Balmert A, Schuster T, Slotta-Huspenina J, Herrmann P, Bader FG, Friess H, Schlag PM, Stein U and Janssen KP: Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer. Ann Surg. 256:763–771. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C and Beljanski M: Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology. 46:318–322. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Kopreski MS, Benko FA, Kwak LW and Gocke CD: Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res. 5:1961–1965. 1999.PubMed/NCBI | |
|
Silva JM, Dominguez G, Silva J, Garcia JM, Sanchez A, Rodriguez O, Provencio M, España P and Bonilla F: Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res. 7:2821–2825. 2001.PubMed/NCBI | |
|
Silva JM, Rodriguez R, Garcia JM, Muñoz C, Silva J, Dominguez G, Provencio M, España P and Bonilla F: Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut. 50:530–534. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Garcia V, Garcia JM, Silva J, Martin P, Peña C, Dominguez G, Diaz R, Herrera M, Maximiano C, Sabin P, et al: Extracellular tumor-related mRNA in plasma of lymphoma patients and survival implications. PLoS One. 4:e81732009. View Article : Google Scholar : PubMed/NCBI | |
|
Stein U, Burock S, Herrmann P, Wendler I, Niederstrasser M, Wernecke KD and Schlag PM: Diagnostic and prognostic value of metastasis inducer S100A4 transcripts in plasma of colon, rectal, and gastric cancer patients. J Mol Diagn. 13:189–198. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Mohammed N, Rodriguez M, Garcia V, Garcia JM, Dominguez G, Peña C, Herrera M, Gomez I, Diaz R, Soldevilla B, et al: EPAS1 mRNA in plasma from colorectal cancer patients is associated with poor outcome in advanced stages. Oncol Lett. 2:719–724. 2011.PubMed/NCBI | |
|
Shen J, Wei J, Guan W, Wang H, Ding Y, Qian X, Yu L, Zou Z, Xie L, Costa C, et al: Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancer. J Transl Med. 12:3552014. View Article : Google Scholar : PubMed/NCBI | |
|
Kishikawa T, Otsuka M, Ohno M, Yoshikawa T, Takata A and Koike K: Circulating RNAs as new biomarkers for detecting pancreatic cancer. World J Gastroenterol. 21:8527–8540. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
García JM, García V, Peña C, Domínguez G, Silva J, Diaz R, Espinosa P, Citores MJ, Collado M and Bonilla F: Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched. RNA. 14:1424–1432. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng Z, Gao S, Yang Z, Xie H, Zhang C, Lin B, Wu L, Zheng S and Zhou L: Single nucleotide polymorphisms in the metastasis-associated in colon cancer-1 gene predict the recurrence of hepatocellular carcinoma after transplantation. Int J Med Sci. 11:142–150. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Siravegna G, Mussolin B, Buscarino M, Corti G, Cassingena A, Crisafulli G, Ponzetti A, Cremolini C, Amatu A, Lauricella C, et al: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat Med. 21:795–801. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Mouliere F, Robert B, Arnau Peyrotte E, Del Rio M, Ychou M, Molina F, Gongora C and Thierry AR: High fragmentation characterizes tumour-derived circulating DNA. PLoS One. 6:e234182011. View Article : Google Scholar : PubMed/NCBI | |
|
Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, et al: Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 6:224ra2242014. View Article : Google Scholar | |
|
Hwang HW and Mendell JT: MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer. 96:(Suppl). R40–R44. 2007.PubMed/NCBI | |
|
Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Wang ZQ, Chen M, Peng L, Wang X, Ma Q, Ma F and Jiang B: MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer. Mol Cancer. 11:232012. View Article : Google Scholar : PubMed/NCBI | |
|
Huang N, Wu Z, Lin L, Zhou M, Wang L, Ma H, Xia J, Bin J, Liao Y and Liao W: MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling. Oncotarget. 6:15222–15234. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Feng J, Wang J, Chen M, Chen G, Wu Z, Ying L, Zhuo Q, Zhang J and Wang W: miR-200a suppresses cell growth and migration by targeting MACC1 and predicts prognosis in hepatocellular carcinoma. Oncol Rep. 33:713–720. 2015.PubMed/NCBI | |
|
Xue Q, Sun K, Deng HJ, Lei ST, Dong JQ and Li GX: MicroRNA-338-3p inhibits colorectal carcinoma cell invasion and migration by targeting smoothened. Jpn J Clin Oncol. 44:13–21. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sun K, Su G, Deng H, Dong J, Lei S and Li G: Relationship between miRNA-338-3p expression and progression and prognosis of human colorectal carcinoma. Chin Med J (Engl). 127:1884–1890. 2014.PubMed/NCBI | |
|
Sheng XJ, Li Z, Sun M, Wang ZH, Zhou DM, Li JQ, Zhao Q, Sun XF and Liu QC: MACC1 induces metastasis in ovarian carcinoma by upregulating hepatocyte growth factor receptor c-MET. Oncol Lett. 8:891–897. 2014.PubMed/NCBI | |
|
Pichler M, Ress AL, Winter E, Stiegelbauer V, Karbiener M, Schwarzenbacher D, Scheideler M, Ivan C, Jahn SW, Kiesslich T, et al: MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients. Br J Cancer. 110:1614–1621. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lin L, Huang H and Liao W, Ma H, Liu J, Wang L, Huang N, Liao Y and Liao W: MACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect. Oncogene. 34:2700–2710. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Hara S, Nakashiro K, Klosek SK, Ishikawa T, Shintani S and Hamakawa H: Hypoxia enhances c-Met/HGF receptor expression and signaling by activating HIF-1alpha in human salivary gland cancer cells. Oral Oncol. 42:593–598. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Chen HH, Su WC, Lin PW, Guo HR and Lee WY: Hypoxia-inducible factor-1alpha correlates with MET and metastasis in node-negative breast cancer. Breast Cancer Res Treat. 103:167–175. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Comito G, Calvani M, Giannoni E, Bianchini F, Calorini L, Torre E, Migliore C, Giordano S and Chiarugi P: HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. Free Radic Biol Med. 51:893–904. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ide T, Kitajima Y, Miyoshi A, Ohtsuka T, Mitsuno M, Ohtaka K and Miyazaki K: The hypoxic environment in tumor-stromal cells accelerates pancreatic cancer progression via the activation of paracrine hepatocyte growth factor/c-Met signaling. Ann Surg Oncol. 14:2600–2607. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Kim BW, Cho H, Chung JY, Conway C, Ylaya K, Kim JH and Hewitt SM: Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry. J Transl Med. 11:1852013. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Z, He X, Xia W, Huang Q, Zhang Z, Ye J, Ni C, Wu P, Wu D, Xu J, et al: Prognostic value and clinicopathological differences of HIFs in colorectal cancer: Evidence from meta-analysis. PLoS One. 8:e803372013. View Article : Google Scholar : PubMed/NCBI | |
|
Hardie DG: The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci. 117:5479–5487. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Loo JM, Scherl A, Nguyen A, Man FY, Weinberg E, Zeng Z, Saltz L, Paty PB and Tavazoie SF: Extracellular metabolic energetics can promote cancer progression. Cell. 160:393–406. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Fűri I, Kalmár A, Wichmann B, Spisák S, Schöller A, Barták B, Tulassay Z and Molnár B: Cell free DNA of tumor origin induces a ‘metastatic’ expression profile in HT-29 cancer cell line. PLoS One. 10:e01316992015. View Article : Google Scholar : PubMed/NCBI | |
|
Fűri I, Sipos F, Germann TM, Kalmár A, Tulassay Z, Molnár B and Műzes G: Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: Clinico-pathogenic aspects. World J Gastroenterol. 19:4119–4126. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Juneja M, Ilm K, Schlag PM and Stein U: Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer. Mol Oncol. 7:929–943. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Stein U, Smith J, Walther W and Arlt F: MACC1 controls Met: What a difference an Sp1 site makes. Cell Cycle. 8:2467–2469. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Lin L, Chen X, Sun L, Liao Y, Huang N and Liao W: Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2. Oncotarget. 6:11492–11506. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Migliore C, Martin V, Leoni VP, Restivo A, Atzori L, Petrelli A, Isella C, Zorcolo L, Sarotto I, Casula G, et al: MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. Clin Cancer Res. 18:737–747. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Shang C, Hong Y, Guo Y, Liu YH and Xue YX: Influence of the MACC1 gene on sensitivity to chemotherapy in human U251 glioblastoma cells. Asian Pac J Cancer Prev. 16:195–199. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yang WJ, Song MJ, Park EY, Lee JJ, Park JH, Park K, Park JH and Kim HP: Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype. Mol Cells. 36:368–375. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gao Y, Liu Z, Zhang X, He J, Pan Y, Hao F, Xie L, Li Q, Qiu X and Wang E: Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells. Cancer Lett. 336:231–239. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wei Y, Shen N, Wang Z, Yang G, Yi B, Yang N, Qiu Y and Lu J: Sorafenib sensitizes hepatocellular carcinoma cell to cisplatin via suppression of Wnt/β-catenin signaling. Mol Cell Biochem. 381:139–144. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao H, Wei W, Sun Y, Gao J, Wang Q and Zheng J: Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model. DNA Cell Biol. 34:55–62. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Xia Y, He Z, Liu B, Wang P and Chen Y: Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway. Mol Med Rep. 12:4530–4537. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Nagaraj AB, Joseph P, Kovalenko O, Singh S, Armstrong A, Redline R, Resnick K, Zanotti K, Waggoner S and DiFeo A: Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance. Oncotarget. 6:23720–23734. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kim YH, Kim G, Kwon CI, Kim JW, Park PW and Hahm KB: TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1. Oncol Rep. 31:1380–1388. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yu H, Jin GZ, Liu K, Dong H, Yu H, Duan JC, Li Z, Dong W, Cong WM and Yang JH: Twist2 is a valuable prognostic biomarker for colorectal cancer. World J Gastroenterol. 19:2404–2411. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L, Nordlinger B, Bretti S, Bottardi S, Giordano S, et al: Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res. 1:147–154. 1995.PubMed/NCBI | |
|
Mao W, Irby R, Coppola D, Fu L, Wloch M, Turner J, Yu H, Garcia R, Jove R and Yeatman TJ: Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene. 15:3083–3090. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng Z, Weiser MR, D'Alessio M, Grace A, Shia J and Paty PB: Immunoblot analysis of c-Met expression in human colorectal cancer: Overexpression is associated with advanced stage cancer. Clin Exp Metastasis. 21:409–417. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng ZS, Weiser MR, Kuntz E, Chen CT, Khan SA, Forslund A, Nash GM, Gimbel M, Yamaguchi Y, Culliford AT IV, et al: c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases. Cancer Lett. 265:258–269. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Osada S, Matsui S, Komori S, Yamada J, Sanada Y, Ihawa A, Tanaka Y, Tokuyama Y, Okumura N, Nonaka K, et al: Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer. Hepatogastroenterology. 57:76–80. 2010.PubMed/NCBI | |
|
Matsui S, Osada S, Tomita H, Komori S, Mori R, Sanada Y, Takahashi T, Yamaguchi K and Yoshida K: Clinical significance of aggressive hepatectomy for colorectal liver metastasis, evaluated from the HGF/c-Met pathway. Int J Oncol. 37:289–297. 2010.PubMed/NCBI | |
|
Sun YL, Liu WD, Ma GY, Gao DW, Jiang YZ, Liu Q and Du JJ: Expression of HGF and Met in human tissues of colorectal cancers: Biological and clinical implications for synchronous liver metastasis. Int J Med Sci. 10:548–559. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Abou-Bakr AA and Elbasmi A: c-MET overexpression as a prognostic biomarker in colorectal adenocarcinoma. Gulf J Oncolog. 1:28–34. 2013.PubMed/NCBI | |
|
Sueta A, Yamamoto Y, Yamamoto-Ibusuki M, Hayashi M, Takeshita T, Yamamoto S, Omoto Y and Iwase H: Differential role of MACC1 expression and its regulation of the HGF/cMet pathway between breast and colorectal cancer. Int J Oncol. 46:2143–2153. 2015.PubMed/NCBI | |
|
Pichorner A, Sack U, Kobelt D, Smith J, Walther W, Schlag PM and Stein U: In vivo imaging of MACC1 induced metastasis formation in a xenograft mouse model based on an IRES-vector harboring the reporter luciferase and the gene MACC1: PO125. Onkologie. 33:652010.PubMed/NCBI |
